U.S. Markets closed

Uroplasty downgraded to Market Perform from Outperform at JMP Securities

JMP Securities downgraded Uroplasty (URI) following the FDA approval of Allergan's (AGN) Botox for the treatment of idiopathic OAB and checks that indicate a faster than expected launch.